JW Pharmaceutical Corporation (KRX:001060)
26,700
-150 (-0.56%)
At close: Dec 26, 2025
JW Pharmaceutical Market Cap
JW Pharmaceutical has a market cap or net worth of 612.11 billion as of December 26, 2025. Its market cap has increased by 8.97% in one year.
Market Cap
612.11B
Enterprise Value
598.26B
Revenue
764.21B
Ranking
n/a
PE Ratio
10.64
Stock Price
26,700.00
Market Cap Chart
Since April 29, 2003, JW Pharmaceutical's market cap has increased from 84.02B to 612.11B, an increase of 628.51%. That is a compound annual growth rate of 9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 612.11B | 8.98% |
| Dec 30, 2024 | 561.70B | -32.21% |
| Dec 28, 2023 | 828.52B | 97.41% |
| Dec 29, 2022 | 419.69B | -17.00% |
| Dec 30, 2021 | 505.68B | -32.85% |
| Dec 30, 2020 | 753.06B | 22.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |